Oral ketotifen associated with famotidine for the treatment of facial melasma: a randomized, double-blind, placebo-controlled trial

J Eur Acad Dermatol Venereol. 2022 Feb;36(2):e123-e125. doi: 10.1111/jdv.17692. Epub 2021 Oct 10.

Authors

J A F Dias¹, P B Lima¹, D P Cassiano², A C C Espósito¹, E Bagatin², L D B Miot¹, H A Miot¹

Affiliations

¹ Departamento de Dermatologia, UNESP, Botucatu, Brazil.
² Departamento de Dermatologia, UNIFESP, São Paulo, Brazil.

PMID: 34553413
DOI: 10.1111/jdv.17692

No abstract available

Publication types

Letter
Randomized Controlled Trial

MeSH terms

Double-Blind Method
Famotidine
Humans
Ketotifen*
Melanosis* / drug therapy

Substances

Famotidine
Ketotifen